Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34145040.
- Also identified by DOI 10.1158/0008-5472.CAN-21-1392 and PMC identifier 8416800.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor metabolism supports the energetic and biosynthetic needs of rapidly proliferating cancer cells and modifies intra- and intercellular signaling to enhance cancer cell invasion, metastasis, and immune evasion. Prostate cancer exhibits unique metabolism with high rates of <i>de novo</i> fatty acid synthesis driven by activation of the androgen receptor (AR). Increasing evidence suggests that activation of this pathway is functionally important to promote prostate cancer aggressiveness. However, the mechanisms by which fatty acid synthesis are beneficial to prostate cancer have not been well defined. In this review, we summarize evidence indicating that fatty acid synthesis drives progression of prostate cancer. We also explore explanations for this phenomenon and discuss future directions for targeting this pathway for patient benefit.
Medical subject headings
- Fatty Acids
- Prostatic Neoplasms
- Receptors, Androgen